To assess the risk of incident cancer associated with the use of lorcaserin in a real-world setting
Latest Information Update: 03 Jan 2022
At a glance
- Drugs Lorcaserin (Primary) ; Phentermine/topiramate
- Indications Obesity
- Focus Adverse reactions
Most Recent Events
- 03 Jan 2022 New trial record
- 05 Nov 2021 Results presented at The Obesity Society: ObesityWeek 2021